My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
09-10 - Texas Opioid Settlement Documents
City-of-Paris
>
City Council
>
Agenda Packets
>
2023
>
03 - MARCH
>
March 13
>
09-10 - Texas Opioid Settlement Documents
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
3/9/2023 4:54:28 PM
Creation date
3/9/2023 4:53:17 PM
Metadata
Fields
Template:
AGENDA
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
60
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
7. For each settlement utilizing a National Fund, the Texas Political <br />Subdivisions need only make one attempt at seeking fees and expenses <br />there. <br />8. The total amount of the Texas Opioid Fee and Expense Fund shall be <br />reduced proportionally, according to the agreed upon allocation of the <br />Texas Subdivision Fund, for any Texas litigating Political Subdivision <br />that (1) fails to enter the settlement; and (2) was filed in Texas state <br />court, and was transferred to the Texas MDL (or removed before or <br />during transfer to the Texas MDL) as of the execution date of this <br />Agreement. <br />D. The Texas Opioid Council and Texas Abatement Fund <br />The Texas Opioid Council and Texas Abatement Fund is described in detail <br />at Exhibit A, incorporated herein by reference. <br />E. Settlement Negotiations <br />1. The State and Negotiating Committee agree to inform each other in <br />advance of any negotiations relating to a Texas -only settlement with a <br />Pharmaceutical Supply Chain Participant that includes both the State and <br />its Political Subdivisions and shall provide each other the opportunity to <br />participate in all such negotiations. Any Texas -only Settlement agreed to <br />with the State and Negotiating Committee shall be subject to the approval <br />10 <br />
The URL can be used to link to this page
Your browser does not support the video tag.